SI3483161T1 - Vmesne spojine za izdelavo entekavirja - Google Patents
Vmesne spojine za izdelavo entekavirjaInfo
- Publication number
- SI3483161T1 SI3483161T1 SI201131972T SI201131972T SI3483161T1 SI 3483161 T1 SI3483161 T1 SI 3483161T1 SI 201131972 T SI201131972 T SI 201131972T SI 201131972 T SI201131972 T SI 201131972T SI 3483161 T1 SI3483161 T1 SI 3483161T1
- Authority
- SI
- Slovenia
- Prior art keywords
- intermediates used
- entecavir
- make
- make entecavir
- intermediates
- Prior art date
Links
- 229960000980 entecavir Drugs 0.000 title 1
- YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/26—Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/18—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C43/196—Ethers having an ether-oxygen atom bound to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/29—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of oxygen-containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/78—Benzoic acid esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Virology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010230153 | 2010-07-15 | ||
| CN201110196709.XA CN102336754B (zh) | 2010-07-15 | 2011-07-13 | 恩替卡韦的合成方法及其中间体化合物 |
| EP18213624.2A EP3483161B1 (en) | 2010-07-15 | 2011-07-15 | Intermediates used to make entecavir |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3483161T1 true SI3483161T1 (sl) | 2021-06-30 |
Family
ID=45468943
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201131738T SI2594569T1 (sl) | 2010-07-15 | 2011-07-15 | Postopek sinteze entekavirja in njegove vmesne spojine |
| SI201131972T SI3483161T1 (sl) | 2010-07-15 | 2011-07-15 | Vmesne spojine za izdelavo entekavirja |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201131738T SI2594569T1 (sl) | 2010-07-15 | 2011-07-15 | Postopek sinteze entekavirja in njegove vmesne spojine |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9309249B2 (sl) |
| EP (2) | EP3483161B1 (sl) |
| JP (3) | JP6105467B2 (sl) |
| KR (2) | KR102107429B1 (sl) |
| CN (3) | CN102336754B (sl) |
| ES (2) | ES2732042T3 (sl) |
| PL (2) | PL2594569T3 (sl) |
| SI (2) | SI2594569T1 (sl) |
| WO (1) | WO2012006964A1 (sl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012000889A (es) | 2009-07-28 | 2012-02-13 | Ono Pharmaceutical Co | Compuesto biciclico y uso del mismo para propositos medicos. |
| CA2705953C (en) | 2010-05-31 | 2018-05-01 | Alphora Research Inc. | Carbanucleoside synthesis and intermediate compounds useful therein |
| CN102336754B (zh) * | 2010-07-15 | 2017-04-12 | 浙江奥翔药业股份有限公司 | 恩替卡韦的合成方法及其中间体化合物 |
| EP2597096A1 (en) * | 2011-11-24 | 2013-05-29 | Esteve Química, S.A. | Process for preparing entecavir and intermediates thereof |
| WO2015051900A1 (en) * | 2013-10-08 | 2015-04-16 | Pharmathen S.A. | Process for the preparation of entecavir through novel intermediates |
| CN105524064B (zh) * | 2014-09-30 | 2017-10-31 | 中国科学院广州生物医药与健康研究院 | 恩替卡韦的合成方法 |
| CN105037363B (zh) * | 2015-07-13 | 2016-08-24 | 山东罗欣药业集团股份有限公司 | 一种恩替卡韦化合物的新合成方法 |
| WO2018003945A1 (ja) * | 2016-06-30 | 2018-01-04 | 小野薬品工業株式会社 | 二環式化合物の製造方法 |
| CN108203435B (zh) * | 2016-12-16 | 2020-09-04 | 正大天晴药业集团股份有限公司 | 一种利用Boc保护基的恩替卡韦的制备方法 |
| CN107163049B (zh) * | 2017-05-31 | 2019-06-18 | 湖北远大生命科学与技术有限责任公司 | 一种恩替卡韦的制备方法 |
| KR20210102364A (ko) * | 2018-12-12 | 2021-08-19 | 얀센 바이오파마, 인코퍼레이트. | 항바이러스제로서의 사이클로펜틸 뉴클레오시드 유사체 |
| CN112625041A (zh) * | 2020-12-25 | 2021-04-09 | 常州博海威医药科技股份有限公司 | 恩替卡韦的新制备方法以及中间体 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6042348A (ja) * | 1983-08-19 | 1985-03-06 | Sagami Chem Res Center | （３−オキソ−１−アルケニル）−シス−ビシクロ〔３．３．０〕オクテン誘導体 |
| EP0134153B1 (en) | 1983-08-19 | 1989-04-19 | Sagami Chemical Research Center | Bicyclo[3.3.0]octane derivative and preparation thereof |
| JPS60166644A (ja) * | 1984-02-10 | 1985-08-29 | Sagami Chem Res Center | シス−ビシクロ〔３．３．０〕オクチリデン誘導体の製造方法 |
| JPS6468367A (en) * | 1987-09-08 | 1989-03-14 | Ono Pharmaceutical Co | Novel bicyclic ethers or lactones |
| DE4024347A1 (de) * | 1990-07-27 | 1992-01-30 | Schering Ag | Cyclopentanderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
| AU4090697A (en) | 1996-09-03 | 1998-03-26 | Bristol-Myers Squibb Company | Improved process for preparing the antiviral agent {1s-(1alpha, 3alpha, 4beta)}-2-amino-1,9-dihydro-9-{4-hydroxy-3-(hydroxymethyl)-2 -methylenecyclopentyl}-6h-purin-6-one |
| ES2397104T3 (es) * | 2002-12-11 | 2013-03-04 | Bristol-Myers Squibb Company | Procedimiento y productos intermedios para la síntesis de entecavir |
| WO2004105231A2 (en) | 2003-05-20 | 2004-12-02 | Epic Communications, Inc. | Smart linearized power amplifier and related systems and methods |
| CN100379736C (zh) | 2005-05-13 | 2008-04-09 | 上海仲夏化学有限公司 | 恩替卡韦的制备方法 |
| CN101130542B (zh) * | 2006-08-24 | 2010-08-04 | 江苏正大天晴药业股份有限公司 | 抗病毒核苷类似物的合成方法 |
| CN101148450A (zh) * | 2007-11-02 | 2008-03-26 | 严红芳 | 一种核苷化合物的制备方法 |
| KR101150254B1 (ko) * | 2008-12-26 | 2012-06-12 | 한미사이언스 주식회사 | 신규 중간체 및 이를 활용한 엔테카비르 제조방법 |
| CA2777018C (en) * | 2009-10-12 | 2014-04-29 | Hanmi Holdings Co., Ltd. | Novel method for preparing entecavir and intermediate used therein |
| US8481728B2 (en) * | 2010-02-16 | 2013-07-09 | Scinopharm Taiwan, Ltd. | Process for preparing entecavir and its intermediates |
| CA2705953C (en) * | 2010-05-31 | 2018-05-01 | Alphora Research Inc. | Carbanucleoside synthesis and intermediate compounds useful therein |
| CN102336754B (zh) * | 2010-07-15 | 2017-04-12 | 浙江奥翔药业股份有限公司 | 恩替卡韦的合成方法及其中间体化合物 |
-
2011
- 2011-07-13 CN CN201110196709.XA patent/CN102336754B/zh active Active
- 2011-07-13 CN CN201710152615.XA patent/CN106928227B/zh active Active
- 2011-07-15 CN CN201180003541.4A patent/CN102630226B/zh active Active
- 2011-07-15 SI SI201131738T patent/SI2594569T1/sl unknown
- 2011-07-15 JP JP2013518944A patent/JP6105467B2/ja active Active
- 2011-07-15 US US13/810,062 patent/US9309249B2/en active Active
- 2011-07-15 PL PL11806306T patent/PL2594569T3/pl unknown
- 2011-07-15 ES ES11806306T patent/ES2732042T3/es active Active
- 2011-07-15 ES ES18213624T patent/ES2874350T3/es active Active
- 2011-07-15 EP EP18213624.2A patent/EP3483161B1/en active Active
- 2011-07-15 SI SI201131972T patent/SI3483161T1/sl unknown
- 2011-07-15 EP EP11806306.4A patent/EP2594569B1/en active Active
- 2011-07-15 WO PCT/CN2011/077195 patent/WO2012006964A1/zh active Application Filing
- 2011-07-15 KR KR1020197014172A patent/KR102107429B1/ko active IP Right Grant
- 2011-07-15 KR KR1020137003701A patent/KR101983033B1/ko active IP Right Grant
- 2011-07-15 PL PL18213624T patent/PL3483161T3/pl unknown
-
2016
- 2016-07-22 JP JP2016144062A patent/JP6573848B2/ja active Active
-
2018
- 2018-04-05 JP JP2018073060A patent/JP2018138559A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102107429B1 (ko) | 2020-05-07 |
| PL3483161T3 (pl) | 2021-09-20 |
| SI2594569T1 (sl) | 2019-10-30 |
| JP6105467B2 (ja) | 2017-03-29 |
| CN102630226B (zh) | 2014-01-22 |
| US9309249B2 (en) | 2016-04-12 |
| EP2594569A4 (en) | 2014-01-08 |
| EP2594569B1 (en) | 2019-03-20 |
| CN102336754A (zh) | 2012-02-01 |
| CN102336754B (zh) | 2017-04-12 |
| EP3483161B1 (en) | 2021-03-03 |
| KR101983033B1 (ko) | 2019-05-28 |
| KR20190059987A (ko) | 2019-05-31 |
| EP2594569A1 (en) | 2013-05-22 |
| ES2874350T3 (es) | 2021-11-04 |
| CN102630226A (zh) | 2012-08-08 |
| EP3483161A1 (en) | 2019-05-15 |
| PL2594569T3 (pl) | 2019-09-30 |
| JP6573848B2 (ja) | 2019-09-11 |
| CN106928227B (zh) | 2020-06-30 |
| WO2012006964A1 (zh) | 2012-01-19 |
| ES2732042T3 (es) | 2019-11-20 |
| JP2018138559A (ja) | 2018-09-06 |
| JP2016196499A (ja) | 2016-11-24 |
| JP2013532174A (ja) | 2013-08-15 |
| KR20130089250A (ko) | 2013-08-09 |
| CN106928227A (zh) | 2017-07-07 |
| US20130217879A1 (en) | 2013-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3483161T3 (pl) | Związki pośrednie do otrzymywania entekawiru | |
| IL226004A0 (en) | New antiviral compounds | |
| GB201015079D0 (en) | Novel use | |
| GB2513057B (en) | Improvements to handover | |
| ZA201209029B (en) | Novel pyrimidine derivatives | |
| GB201012105D0 (en) | Novel pyrimidine compounds | |
| GB2489486B (en) | Improvements relating to construction | |
| ZA201206924B (en) | Novel use | |
| AP2015008378A0 (en) | Improvements relating to buoyancy-supported risers | |
| IL222506A0 (en) | Alternative to tetrazene | |
| GB201020990D0 (en) | Improvements relating to trams | |
| GB2478170B (en) | Improvements relating to dc-dc coverters | |
| HK1160777A1 (en) | Novel use of neohesperidoside | |
| GB2510504B (en) | Improvements to handover | |
| IL243320A0 (en) | Intermediates of teroarylpiperidine and piperazine derivatives | |
| GB201116456D0 (en) | Improvements relating to foorwear | |
| TWM390745U (en) | Structure improvement of tea-making can | |
| GB201013445D0 (en) | Made to go! | |
| GB201016008D0 (en) | Improvements to lighting | |
| TWM389392U (en) | Structural improvement of charger | |
| TWM400763U (en) | Improved structure of cold-accumulating cravats | |
| TWM388315U (en) | Improved structure of hemoclip | |
| HU1000688D0 (en) | Use of trifluoro-phal | |
| TWM389753U (en) | Improved structure of handle | |
| GB201001372D0 (en) | Brickies aid to pillars |